Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Patients should never adjust or discontinue either antidepressants or GLP-1 medications without explicit guidance from their treating physicians, as abrupt changes can trigger depression relapse or rebound appetite issues
One of the most notable investigations, the STEP 1 trial published in The New England Journal of Medicine, reported that participants receiving weekly GLP1-S alongside lifestyle interventions experienced an average 14.9% decrease in body weight across 68 weeks[7][8]
Meanwhile, doctors advise Wegovy pill patients not to eat or drink for 30 minutes after taking the medication
Tirzepatide through Pomegranate Health: what to expect Tirzepatide has become the preferred GLP-1 medication for many patients due to its dual-action mechanism and potentially greater weight loss outcomes
Tirzepatide (commonly sold under the brand name Mounjaro) has gained massive popularity as an effective treatment for type 2 diabetes and weight loss
US$ 25.48
US$ 24.23
US$ 24.19
